Sign In
Buy BSX
$47.69
+0.0100 (+0.0210%)
At Close: Jun 03, 2026
Altfest L J & Co. Inc. Decreases Stock Holdings in Boston Scientific Corporation $BSX
05:04am, Saturday, 03'rd Jan 2026
Altfest L J and Co. Inc. lowered its holdings in Boston Scientific Corporation (NYSE: BSX) by 31.7% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Excha
Brookwood Investment Group LLC Purchases 7,138 Shares of Boston Scientific Corporation $BSX
03:46am, Saturday, 03'rd Jan 2026
Brookwood Investment Group LLC increased its position in Boston Scientific Corporation (NYSE: BSX) by 119.9% during the third quarter, according to the company in its most recent 13F filing with the S
MARLBOROUGH, Mass., Jan. 2, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in the 44th Annual J.P.
Generali Asset Management SPA SGR Purchases 6,433 Shares of Boston Scientific Corporation $BSX
05:14am, Friday, 02'nd Jan 2026
Generali Asset Management SPA SGR boosted its position in shares of Boston Scientific Corporation (NYSE: BSX) by 7.7% in the third quarter, according to its most recent Form 13F filing with the Securi
Bank Pictet & Cie Europe AG Cuts Stock Holdings in Boston Scientific Corporation $BSX
03:28am, Friday, 02'nd Jan 2026
Bank Pictet and Cie Europe AG trimmed its stake in Boston Scientific Corporation (NYSE: BSX) by 4.1% during the undefined quarter, according to the company in its most recent disclosure with the Secur
How Is Boston Scientific's Cardiovascular Growth Path Shaping Up?
08:25am, Wednesday, 31'st Dec 2025
BSX's $50B cardiovascular business aims to outpace market growth across EP, WATCHMAN, ICTx and more.
Calamos Advisors LLC Sells 244,349 Shares of Boston Scientific Corporation $BSX
06:58am, Wednesday, 31'st Dec 2025
Calamos Advisors LLC reduced its position in shares of Boston Scientific Corporation (NYSE: BSX) by 21.5% in the undefined quarter, according to the company in its most recent Form 13F filing with the
Calamos Wealth Management LLC Buys 53,252 Shares of Boston Scientific Corporation $BSX
05:42am, Wednesday, 31'st Dec 2025
Calamos Wealth Management LLC boosted its stake in Boston Scientific Corporation (NYSE: BSX) by 52.3% during the third quarter, according to the company in its most recent filing with the SEC. The fun
BSX vs. RMD: Which Medical Device Stock Is the Stronger Play Now?
09:21am, Tuesday, 30'th Dec 2025
Boston Scientific edges out Resmed as WATCHMAN momentum, EP gains and acquisitions fuel stronger recent price performance in a growing medical device market.
Sowell Financial Services LLC Sells 28,806 Shares of Boston Scientific Corporation $BSX
05:54am, Monday, 29'th Dec 2025
Sowell Financial Services LLC cut its position in Boston Scientific Corporation (NYSE: BSX) by 51.1% in the undefined quarter, according to its most recent filing with the Securities and Exchange Comm
Boston Scientific: Premium MedTech Growth Story With Attractive Valuation Upside
02:40am, Sunday, 28'th Dec 2025
Boston Scientific is recommended as a buy with a $109 target price, implying 14% upside, driven by robust demand and niche leadership. BSX outpaces market growth through focused M&A, strong execution
PAHC or BSX: Which Is the Better Value Stock Right Now?
12:42pm, Wednesday, 24'th Dec 2025
Investors interested in Medical - Products stocks are likely familiar with Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks presents investors with the better val
How Well Is Boston Scientific Placed for Long-Term Endoscopy Growth?
09:41am, Wednesday, 24'th Dec 2025
BSX's Endoscopy unit targets an $8B market, spanning pancreaticobiliary, surgery and obesity, with plans to outgrow the market.
Is Fidelity Medical Equipment the Ultimate "Forever Fund" for Health Care Investors?
07:45am, Wednesday, 24'th Dec 2025
This basket of 64 medical device stocks could raise its dividend for decades.
Exchange Traded Concepts LLC Boosts Holdings in Boston Scientific Corporation $BSX
04:08am, Wednesday, 24'th Dec 2025
Exchange Traded Concepts LLC increased its holdings in shares of Boston Scientific Corporation (NYSE: BSX) by 54.4% during the undefined quarter, according to the company in its most recent 13F filing
